Invel Pharmaceuticals LLP

Invel Pharmaceuticals LLP - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
LLPIN AAQ-6421 Incorporated 25 September 2019 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Limited Liability Partnership pharma MSME · Micro
Data last updated
Revenue · FY 2023
₹21.55 Lakh
▼ 3% YoY
Net profit · FY 2023
₹71,611
Net margin 3.3%
EBITDA · FY 2023
-₹2,236
EBITDA margin -0.1%
Contribution obligation
₹1 Lakh
As per LLP agreement
LLP age
7 yrs
Est. 2019
Designated partners
2
As per MCA filings
Last financials
Mar 2024
Balance sheet date
LLP status
Active
MCA master data

About Invel Pharmaceuticals LLP

Data last updated:

Invel Pharmaceuticals LLP is a limited liability partnership (LLP) based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 25 September 2019 and has been in existence for over 7 years.

The LLP is registered with the Registrar of Companies (ROC), Hyderabad, under LLPIN AAQ-6421.

The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners Krishna Bhavani Kona and Seetha Ramulu Kompella.

Its latest statement of accounts is for the year ended 31 March 2024. The registered office is at No 2 – 4 – 149 2nd Floor 202 Jr Edifice, Snehapuri Colony X Road Nagole Hyderabad, Telangana, India – 500035.

As per the financials filed for FY 2023, the LLP reported a revenue of ₹21.55 Lakh, a decline of 3% compared to the previous year. For the same year it recorded a net profit of ₹71,611 (net margin 3.3%) and EBITDA of -₹2,236 (EBITDA margin -0.1%).

Court records list 2 cases involving the LLP, including 2 filed against it; 2 cases are pending.

Invel Pharmaceuticals LLP is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-09-0011397).

Company details

LLPIN AAQ-6421
Incorporation Date 25 September 2019
Total Obligation of Contribution ₹1 Lakh
ROC Hyderabad
Company Status Active
Date of Last AGM 31 March 2024
Date of Balance Sheet 31 March 2024
MSME Classification Micro
Udyam Registration UDYAM-TS-09-0011397
Key People
Krishna Bhavani Kona Designated Partner Seetha Ramulu Kompella Designated Partner

Recognitions & Rankings of Invel Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2023-24)
Udyam number
UDYAM-TS-09-0011397

Contact details

Invel Pharmaceuticals LLP's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.

  • Email
  • Registered Address
    No 2 – 4 – 149 2nd Floor 202 Jr Edifice, Snehapuri Colony X Road Nagole Hyderabad, Telangana, India – 500035
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Invel Pharmaceuticals LLP, buy the company report.

Comprehensive company report
Invel Pharmaceuticals LLP - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Invel Pharmaceuticals LLP

FY 2024 filings available

Invel Pharmaceuticals LLP reported revenue of ₹21.55 Lakh (down 3% YoY) for FY 2023.

Revenue · FY 2023
₹21.55 Lakh ▼ 3%
Net profit · FY 2023
₹71,611 margin 3.3%
EBITDA · FY 2023
-₹2,236 margin -0.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 3%

Revenue fell 3% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

Statement of Account and SolvencyFY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income and Expenditure
Turnover
Other Income
Total Income₹21.55 Lakh
Purchases and Direct Costs
Personnel Expenses
Administrative Expenses
Interest
Depreciation
Total Expenses
Profit Before Tax
Tax
Profit After Tax₹71,611
Profit Transferred to Partners
Assets and Liabilities
Partners' Contribution
Reserves and Surplus
Secured Loans
Unsecured Loans
Trade Payables
Other Liabilities and Provisions
Total Liabilities
Fixed Assets
Investments
Loans and Advances
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

Statement of Account and SolvencyFY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
Net Profit Margin3.3%
Return on Partners' Funds
Return on Assets
Liquidity and Debt
Current Ratio
Debt to Partners' Funds
Interest Coverage
Efficiency and Growth
Asset Turnover
Receivable Days
Turnover Growth
Profit Growth

To see the full financial statements and ratios of Invel Pharmaceuticals LLP, buy the company report.

Designated partners of Invel Pharmaceuticals LLP

Invel Pharmaceuticals has 2 current designated partners and 1 former designated partner. Current designated partners are listed first, with their designation and appointment date.

Current Designated Partners
NameDesignationAppointment DateTenureStatus
Krishna Bhavani KonaDesignated Partner25 Sep 20197 Years 1 MonthsCurrent
Seetha Ramulu KompellaDesignated Partner01 Jul 20224 Years 4 MonthsCurrent
View all designated partners

MSME payment delays

No delayed payments to MSME suppliers are on our record for Invel Pharmaceuticals LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Invel Pharmaceuticals LLP; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Invel Pharmaceuticals LLP has 3 designated partner changes on record since 2019: 2 appointments and 1 cessation. The latest: Renuka Mahalakshmi Kona ceased to be Designated Partner on 01 Jul 2022.

AGM
Invel Pharmaceuticals Llp last Annual general meeting of members was held on 31 Mar 2024 as per latest MCA records.
Filing
Invel Pharmaceuticals Llp has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Ceased
Renuka Mahalakshmi Kona ceased to be Designated Partner.
Appointed
Seetha Ramulu Kompella was appointed as Designated Partner.
Appointed
Krishna Bhavani Kona was appointed as Designated Partner.
Incorporation
25 Sep 2019
Invel Pharmaceuticals Llp was registered on 25 Sep 2019 with Roc Hyderabad & aged 7 years 1 month as per MCA records.

Frequently asked questions

Invel Pharmaceuticals is an active limited liability partnership based in Hyderabad, Telangana, India. The LLP works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 25 September 2019 (7+ years old) and is registered under LLPIN AAQ-6421.

Invel Pharmaceuticals has 2 current designated partners:

The latest financial statements of Invel Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 31 March 2024. Year-wise statements from FY 2020 are in the company report.

The LLPIN (Limited Liability Partnership Identification Number) of Invel Pharmaceuticals is AAQ-6421. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.

Invel Pharmaceuticals has 2 court cases on record: 2 filed against it. 2 are pending.

Invel Pharmaceuticals was incorporated on 25 September 2019, making it 7+ years old. It is registered with the Registrar of Companies, Hyderabad.

Renuka Mahalakshmi Kona ceased to be Designated Partner on 01 Jul 2022. Seetha Ramulu Kompella was appointed as Designated Partner on 01 Jul 2022. Krishna Bhavani Kona was appointed as Designated Partner on 25 Sep 2019.

Yes, Invel Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-09-0011397).

The registered office of Invel Pharmaceuticals is at No 2 – 4 – 149 2nd Floor 202 Jr Edifice, Snehapuri Colony X Road Nagole Hyderabad, Telangana, India – 500035.

Invel Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.